114 related articles for article (PubMed ID: 37952317)
1. Nanopore-related cellular death through cytoskeleton depolymerization by drug-induced ROS.
Zhang Y; Xu R; Wu J; Zhang Z; Wang Y; Yang H; Zhang S
Talanta; 2024 Feb; 268(Pt 2):125355. PubMed ID: 37952317
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel Induces the Apoptosis of Prostate Cancer Cells via ROS-Mediated HIF-1α Expression.
Zhang Y; Tang Y; Tang X; Wang Y; Zhang Z; Yang H
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364008
[TBL] [Abstract][Full Text] [Related]
3. Qualitative and Quantitative Analysis of ROS-Mediated Oridonin-Induced Oesophageal Cancer KYSE-150 Cell Apoptosis by Atomic Force Microscopy.
Pi J; Cai H; Jin H; Yang F; Jiang J; Wu A; Zhu H; Liu J; Su X; Yang P; Cai J
PLoS One; 2015; 10(10):e0140935. PubMed ID: 26496199
[TBL] [Abstract][Full Text] [Related]
4. An Atomic Force Microscope Study Revealed Two Mechanisms in the Effect of Anticancer Drugs on Rate-Dependent Young's Modulus of Human Prostate Cancer Cells.
Ren J; Huang H; Liu Y; Zheng X; Zou Q
PLoS One; 2015; 10(5):e0126107. PubMed ID: 25932632
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy induces unfolded protein response and cytoskeletal rearrangement leading to mitochondrial apoptosis in prostate cancer.
Kumar S; Chaudhary AK; Kumar R; O'Malley J; Dubrovska A; Wang X; Yadav N; Goodrich DW; Chandra D
Mol Oncol; 2016 Aug; 10(7):949-65. PubMed ID: 27106131
[TBL] [Abstract][Full Text] [Related]
6. Nanomechanics in Monitoring the Effectiveness of Drugs Targeting the Cancer Cell Cytoskeleton.
Kubiak A; Zieliński T; Pabijan J; Lekka M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233645
[TBL] [Abstract][Full Text] [Related]
7. Zerumbone-induced reactive oxygen species-mediated oxidative stress re-sensitizes breast cancer cells to paclitaxel.
Li J; Wang L; Sun Y; Wang Z; Qian Y; Duraisamy V; Antary TMA
Biotechnol Appl Biochem; 2023 Feb; 70(1):28-37. PubMed ID: 35240000
[TBL] [Abstract][Full Text] [Related]
8. Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA-Paclitaxel Conjugate.
Lv Q; Yang J; Zhang R; Yang Z; Yang Z; Wang Y; Xu Y; He Z
Mol Pharm; 2018 May; 15(5):1842-1852. PubMed ID: 29608845
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. The selective cytotoxicity of DSF-Cu attributes to the biomechanical properties and cytoskeleton rearrangements in the normal and cancerous nasopharyngeal epithelial cells.
Yang Y; Li M; Sun X; Zhou C; Wang Y; Wang L; Chen L; Liang Z; Zhu L; Yang H
Int J Biochem Cell Biol; 2017 Mar; 84():96-108. PubMed ID: 28111334
[TBL] [Abstract][Full Text] [Related]
11. Zinc promotes prostate cancer cell chemosensitivity to paclitaxel by inhibiting epithelial-mesenchymal transition and inducing apoptosis.
Xue YN; Yu BB; Liu YN; Guo R; Li JL; Zhang LC; Su J; Sun LK; Li Y
Prostate; 2019 May; 79(6):647-656. PubMed ID: 30714183
[TBL] [Abstract][Full Text] [Related]
12. Increased paclitaxel cytotoxicity against cancer cell lines using a novel functionalized carbon nanotube.
Sobhani Z; Dinarvand R; Atyabi F; Ghahremani M; Adeli M
Int J Nanomedicine; 2011; 6():705-19. PubMed ID: 21556345
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy.
Pandya AD; Jäger E; Bagheri Fam S; Höcherl A; Jäger A; Sincari V; Nyström B; Štěpánek P; Skotland T; Sandvig K; Hrubý M; Mælandsmo GM
Int J Nanomedicine; 2019; 14():6269-6285. PubMed ID: 31496685
[TBL] [Abstract][Full Text] [Related]
14. Nanopore formation process in artificial cell membrane induced by plasma-generated reactive oxygen species.
Tero R; Yamashita R; Hashizume H; Suda Y; Takikawa H; Hori M; Ito M
Arch Biochem Biophys; 2016 Sep; 605():26-33. PubMed ID: 27216034
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
Li X; Han X; Wei P; Yang J; Sun J
Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
[TBL] [Abstract][Full Text] [Related]
16. Nanoscale Features of Gambogic Acid Induced ROS-Dependent Apoptosis in Esophageal Cancer Cells Imaged by Atomic Force Microscopy.
Liu J; Fan S; Xiang Y; Xia J; Jin H; Xu JF; Yang F; Cai J; Pi J
Scanning; 2022; 2022():1422185. PubMed ID: 35937670
[TBL] [Abstract][Full Text] [Related]
17. Combination of metformin and paclitaxel suppresses proliferation and induces apoptosis of human prostate cancer cells via oxidative stress and targeting the mitochondria-dependent pathway.
Zhao Y; Zeng X; Tang H; Ye D; Liu J
Oncol Lett; 2019 May; 17(5):4277-4284. PubMed ID: 30944622
[TBL] [Abstract][Full Text] [Related]
18. The orally active pterocarpanquinone LQB-118 exhibits cytotoxicity in prostate cancer cell and tumor models through cellular redox stress.
Martino T; Kudrolli TA; Kumar B; Salviano I; Mencalha A; Coelho MGP; Justo G; Costa PRR; Sabino KCC; Lupold SE
Prostate; 2018 Feb; 78(2):140-151. PubMed ID: 29105806
[TBL] [Abstract][Full Text] [Related]
19. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
20. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S
Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
